Related Experiment Video
Updated: May 10, 2026
05:30
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
Total laparoscopic distal gastrectomy with Roux-en Y reconstruction
Jung Ho Shim1, Jun Gi Kim, Han Mo Yoo
1Department of Surgery, Division of Gastrointestinal Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Summary
Total laparoscopic distal gastrectomy (TLDG) with Roux-en Y (RY) reconstruction is a safe and effective surgical technique for gastric cancer. This study demonstrates its technical feasibility and positive patient outcomes.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
- Gastrointestinal Surgery
Background:
- Gastric cancer necessitates surgical intervention, with distal gastrectomy being a common procedure.
- Laparoscopic approaches offer potential benefits over open surgery.
- Roux-en Y reconstruction is a standard method for gastrointestinal continuity after gastric resection.
Purpose of the Study:
- To introduce a specific technique for Roux-en Y reconstruction following total laparoscopic distal gastrectomy (TLDG).
- To evaluate the technical efficacy and early postoperative outcomes of this TLDG with RY reconstruction method.
Main Methods:
- A consecutive series of 38 gastric adenocarcinoma patients underwent TLDG with a custom RY-type anastomosis.
- Surgical techniques and postoperative outcomes were meticulously assessed.
- Endoscopic evaluation was performed to check for bile reflux.
Main Results:
- The mean operative time was 144.5 minutes, with reconstruction taking 26.2 minutes.
- The majority of patients had early-stage disease (IA/IB).
- Postoperative hospital stay averaged 8.3 days; two patients required reoperation for internal herniation, and no bile reflux was observed.
Conclusions:
- Total laparoscopic distal gastrectomy (TLDG) combined with Roux-en Y (RY) reconstruction is a technically feasible procedure.
- This approach demonstrates acceptable outcomes for gastric cancer patients.
